28/11/2015 11:14:21 Cookie Policy Free Membership Login

Ark Ther Grp Share Chat - AKT

Share Name Share Symbol Market Type Share ISIN Share Description
Ark Therapeutics Group LSE:AKT London Ordinary Share GB00BSZLMS59 ORD 10P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00 +0.00% 63.25 0.00 0.00 - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.1 0.5 126.5 132.37

ARK Therapeutics Share Discussion Threads

Showing 3651 to 3673 of 3675 messages
Post New Message
Chat Pages: 147  146  145  144  143  142  141  140  139  138  137  136  >>
Please note the thread for PVG created by pet lover on Tuesday of this week (10th. March): "DOG AND CAT OWNERS (PVG)" http://uk.advfn.com/cmn/fbb/thread.php3?id=33650414 PVG currently 63.5p: a very nice premium to the 10.1p placing price!!hedgehog 100
I might even get my money back if this continues like this over the next year!!joeblogg2
The free float is so small now and the BOD have huge amounts at stake.joeblogg2
Raj Uppal is a very good operator, who makes money...this will do well.errollc
Slowly edging up. Would buy more to bring my average down but sadly no funds as I feel they have a good model and met Rajan Uppal who has made a lot of money in his ventures and I think will do well here as has a big stake!!joeblogg2
With stock so limited any good news could really see this rocket. Just checking and Barclays won't let me buy online and have to telephone them but can sell my 20k no problem as could not sell them on Friday so looks like there is a buyer.joeblogg2
EJ, The directors here do seem to be very good at looking after themselves. They allowed themselves to invest in the placing at 10.1p, a discount of over 80% to the suspended share price consolidation-adjusted. Normal retail shareholders did not have that opportunity. And after the first day of trading back from suspension on Friday, the share price is now at 28.5p. And it was announced late in Friday afternoon trading that they have granted two of themselves options at 10.1p: 27/02/2015 16:07 UKREG Ark Therapeutics Group PLC Board Changes and Directors' Dealings London, UK, 27 February 2015 (LSE: AKT): The Company announces that it has today issued options to subscribe for new ordinary shares of 10 pence each in its capital, including awards to the following Directors: Name Role Number of options Exercise price per share --------------- -------------------- ----------------------- --------------- Dominic Tonner Director (Chief 279,035 10.1 pence Executive Officer) --------------- -------------------- ----------------------- --------------- Daniel Smith Director (Chief 209,277 10.1 pence Financial Officer) --------------- -------------------- ----------------------- --------------- Each of the above options was granted pursuant to the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan. As outlined in the Circular issued to Shareholders on 21 November 2014 (the "Circular") and the Prospectus published on 26 February 2015 (the "Prospectus"), the options were granted at an exercise price equal to the Subscription Price (as defined in the Circular and the Prospectus) of 10.1 pence, and will vest in full on the later of the first anniversary of the date of grant and the date that the market price of an ordinary share is at least twice the Subscription Price, and has been for a continuous period for 15 days. No consideration was paid for the grant of options. ... " http://uk.advfn.com/news/UKREG/2015/article/65662354hedgehog 100
bigglesbingham - I concur. I had a contemptuous email from him some months ago and not the dignity of reply in one I sent around a month ago. It was inevitable that the share price halved when suspension lifted - I reckon a further 90% fall. Now, I have many medical friends and know two vets very slightly. I cannot believe for a moment that their practices are loss making other than for taxation purpose. For continual losses to incur is, I suggest, easily explained with the payment of over generous drawings and the filtering of private expenses that are not wholly and necessarily incurred to run the business. A good example is the annual skiing jolly. These are entirely allowable in full - so 3 weeks holiday in Switzerland with a series of lectures lined up in the evenings discussing advances in fractures/analgesics/techniques OR a slide presentation on some missionary work while visiting Botswana and the entire vacation is allowable - including sustenance etc. I do hope that now this is a publicly quoted outfit, the AGM will be attended and the accounts are given a little more airing than has been the case in previous years. In the meanwhile, you might like to know that Ross replied to me while he was in Australia. I wonder if he was there on business.erogenous jones
I make it 50% down on value we would have got if they had just closed company and distributed monies rather than reverse take over. Anyone disagree? Ross is ineptbigglesbingham
At least we are back up and runningcurlly
Not much interest here any more :((joeblogg2
TBM, any thoughts on how this will develop?joeblogg2
Same here.zapa
Back trading, I will need over £2 to break even here :((joeblogg2
Cynically, my take is that the time limit in suspension will be just sufficient for the remaining cash to be swallowed up in fees and emoluments.erogenous jones
28/01/2015 09:29 UKREG Ark Therapeutics Group PLC Sale and Purchase Agreement Signed "Sale and Purchase Agreement Signed London, UK, 28 January 2015 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that, as foreshadowed in the Company's announcement and in its circular to shareholders, in each case dated 21 November 2014, it has entered into a share sale and purchase agreement with Rajan Uppal, Dominic Tonner and Berkeley Burke Trustee Company Limited to acquire 75.8% of the issued share capital of Premier Veterinary Group Limited ("PVG"). The aggregate consideration payable to all PVG shareholders is GBP3,731.18 in cash. The sellers have invoked the drag-along provisions contained in PVG's articles of association to enable the Company to acquire the entire issued share capital of PVG. Completion of the acquisition is scheduled to occur on 5 February 2015. The Company's shares will remain suspended until further notice but, as set out in the circular of 21 November 2014, it is the intention of the Company to publish a prospectus and to seek readmission of the Company's shares on the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. A further announcement will be made in due course." http://uk.advfn.com/news/UKREG/2015/article/65258218 Though completion of the acquisition is due next week (Thursday), they don't say that the prospectus will be published then, and until that happens the suspension can't be lifted. As AKT is main-listed rather than AIM-listed, there is no time-limit for the suspension period (AIM has a 6-month limit).hedgehog 100
I might have touched on a nerve as there is a holding RNS issued today.erogenous jones
Still no sign of prospectus, Hedghog 100. Total shambles from Ross as far as I am concerned. As for bed partner, well, little evidence so far that this is a business that is slick and organised. I warrant that a listing is simply to be able in time to raise funds rather than growing business organically. That the vetinary business is loss making, is unusual, I would have thought. Mind you, higher education is no guarantee of financial competence. Surely this cannot be so complicated a merge/takeover to take so long? Could this be regulatory, NOMAD or to squander the remaining cash to line the trousers of those claiming to have the best interests of shareholders at heart?erogenous jones
On or around today: 21/11/2014 17:48 UKREG Ark Therapeutics Group PLC Posting of Circular "10. Expected timetable of principal events Time and/or date ... Date upon which cancellation of the 14 January 2015 premium listing category will become effective Expected date of completion of the on or around 20 January Acquisition 2015 Expected date of publication of the on or around 21 January Prospectus 2015 ... http://uk.advfn.com/news/UKREG/2014/article/64525276 The transfer from the official list has gone ahead, so I would expect further news imminently: 15/01/2015 07:00 UKREG Ark Therapeutics Group PLC Transfer of listing category on the Official List "London, UK, 15 January 2015 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that, following the passing of the relevant resolution by its shareholders at the Company's General Meeting on 11 December 2014, the Company's listing category will be transferred from "premium listing (commercial company)" to "standard listing" as of 8.00 am today. The Company's ordinary shares will remain suspended pending the publication of a prospectus in relation to the proposed acquisition of Premier Veterinary Group Limited, which constitutes a reverse takeover." http://uk.advfn.com/news/UKREG/2015/article/65108258hedgehog 100
No sign of the prospectus. It was due to be published today.erogenous jones
Another related company - and a large one - to AKT's RTO (reverse takeover) Premier Veterinary Group(PVG): Pets At Home Group (PETS) 201.3p Market cap. £1,006.5M. http://uk.advfn.com/p.php?pid=quote&symbol=PETShedgehog 100
It's just that one sees other great deals that shells have achieved, and this is what our directors have achieved - over £3 million in debt if you included the arrangement fee and final pay-off!!!!mypension
I think my once 4k investment here is now worth £40. Can't say that I am going to lose any sleep on this one way or another. I'd rather it carried on as a listed company so at least if I did come to sell them I would be able to write them off against my other booming investments (that I hasten to point out I have not yet found).dr biotech
Chat Pages: 147  146  145  144  143  142  141  140  139  138  137  136  >>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 151128 11:14